X
THC icon

Xponance’s Tenet Healthcare THC Stock Holding History

Xponance’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.96M Sell
10,498
-254
-2% -$46.7K 0.01% 597
2026
Q1 		$2.03M Buy
10,752
+2,435
+29% +$513K 0.01% 570
2025
Q4 		$1.65M Sell
8,317
-1,684
-17% -$340K 0.01% 578
2025
Q3 		$2.03M Sell
10,001
-448
-4% -$79.5K 0.02% 542
2025
Q2 		$1.84M Sell
10,449
-604
-5% -$90.9K 0.02% 554
2025
Q1 		$1.49M Buy
11,053
+124
+1% +$16.3K 0.01% 583
2024
Q4 		$1.38M Buy
10,929
+497
+5% +$73.9K 0.01% 619
2024
Q3 		$1.73M Sell
10,432
-756
-7% -$114K 0.02% 553
2024
Q2 		$1.49M Sell
11,188
-931
-8% -$112K 0.02% 571
2024
Q1 		$1.27M Sell
12,119
-218
-2% -$19.6K 0.01% 656
2023
Q4 		$932K Buy
12,337
+147
+1% +$9.32K 0.01% 694
2023
Q3 		$803K Sell
12,190
-218
-2% -$16.3K 0.01% 718
2023
Q2 		$1.01M Sell
12,408
-1,925
-13% -$137K 0.01% 644
2023
Q1 		$852K Sell
14,333
-22
-0.2% -$1.22K 0.01% 707
2022
Q4 		$700K Buy
14,355
+1,566
+12% +$72.4K 0.01% 770
2022
Q3 		$660K Buy
12,789
+35
+0.3% +$2.08K 0.01% 723
2022
Q2 		$670K Sell
12,754
-2,868
-18% -$200K 0.01% 733
2022
Q1 		$1.34M Sell
15,622
-242
-2% -$19.9K 0.02% 497
2021
Q4 		$1.3M Sell
15,864
-175
-1% -$12.8K 0.02% 510
2021
Q3 		$1.07M Sell
16,039
-772
-5% -$54.8K 0.02% 528
2021
Q2 		$1.13M Buy
16,811
+5,095
+43% +$316K 0.02% 537
2021
Q1 		$609K Sell
11,716
-2,315
-16% -$117K 0.01% 689
2020
Q4 		$560K Buy
14,031
+34
+0.2% +$1.1K 0.01% 685
2020
Q3 		$343K Sell
13,997
-105
-0.7% -$2.68K 0.01% 807
2020
Q2 		$255K Buy
+14,102
New +$278K 0.01% 882

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Xponance's THC Position: Q2 2026 in Review

Xponance reduced its Tenet Healthcare (THC) stake by 2.4% in Q2 2026, selling an estimated $46.7K and leaving 10,498 shares worth $1.96M. The position accounts for 0.01% of the portfolio, ranked #597.

Xponance first reported a position in THC in Q2 2020 and has held it in 25 quarters since. The position peaked at $2.03M in Q3 2025. 678 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Xponance held 10,498 shares of Tenet Healthcare worth $1.96M as of Q2 2026.
  • Xponance sold 254 Tenet Healthcare shares in Q2 2026, an estimated $46.7K.
  • Tenet Healthcare made up 0.01% of Xponance's portfolio in Q2 2026, its #597 holding.
  • Xponance first reported a position in Tenet Healthcare in Q2 2020 and has held it in 25 quarters since.
  • Xponance's Tenet Healthcare position peaked at $2.03M in Q3 2025.
  • 678 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.